Sen. Casey calls for federal investigation into CDC emails on Legionnaires’ outbreak

U.S. Sen. Bob Casey said today he will ask for a formal federal inquiry into how the Centers for Disease Control and Prevention handled its investigation of the 2012 Legionnaires' outbreak at the Veterans Affairs Pittsburgh Healthcare System, following publication of the Pittsburgh Post-Gazette's two-part series that raised questions about possible bias by federal officials. "It is of great concern to me and should be to anyone interested in this that there could be bias in the CDC's results in this investigation" of the Pittsburgh VA Legionnaires' outbreak, Mr. Casey said.

This Marijuana Company’s in Hot Water With the DOJ

Ongoing investigations into the marketing of its once high-flying fentanyl spray, Subsys, have taken a lot of the luster off Insys Therapeutics ' attempt to reshape marijuana's use as medicine. Today, investigations by the Justice Department led to the arrest of former Insys Therapeutics employees, including former CEO Michael Babich, casting more uncertainty on this company's future.

Woman battling cancer ‘humiliated,’ ‘violated’ during TSA search

The woman posted a video of the search to Facebook in hopes no one else would have to go through she went through. NEW YORK CITY A woman who has been battling breast cancer says an aggressive pre-flight screening, including a public body cavity search, left her feeling humiliated and violated.

Trump’s choice for top China diplomat has long ties to Xi

It may seem odd for the governor of a lightly populated agricultural state to be chosen as U.S. ambassador to China, especially amid escalating talk of a trade war with the major U.S. trading partner. But Iowa Gov. Terry Branstad boasts a 30-year relationship with Chinese President Xi Jinping, the most powerful Chinese leader in decades.

Five Key Things Healthcare Consumers Must Know

With the costs of healthcare rising under Obamacare, consumers need to keep a few things in mind when navigating the complexities of the healthcare system. Robin Gelburd, president of FAIR Health , a national, independent, nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance, provides five key things for consumers to keep in mind when considering healthcare plans.

Rep. Tim Murphy, R-Pa., embraces Rep. Fred Upton, R-Mich., during a…

A sprawling health bill expected to pass the Senate, gain President Obama's signature and become law before the end of the year is a grab bag for industries, academic institutions and patient groups that spent oodles of time and money lobbying to advance their interests. The law would likely save drug and device companies billions of dollars when it comes to bringing products to market by giving the Food and Drug Administration more discretion in the kinds of studies required to evaluate new devices and medicines for approval.

Insulin Prices Skyrocket, Putting Many Diabetics in a Bind

Insulin, a life-saving medication used to treat diabetes, was discovered nearly 100 years ago, yet the price of the drug has now spiked by 700 percent in just two decades. In early November, Sen. Bernie Sanders, the Vermont Democrat, pointed out that certain insulins had risen from $21 a vial in 1996 to $255 a vial in 2016.

Migrants Banned from Leaving Refugee Camp After Reports of Viral Infections and Smallpox

Migrants living at the Harmanli camp in Bulgaria are on lockdown after reports of infectious disease including viral infections and smallpox. 3,000 migrants living in a camp in Bulgaria are on lockdown after reports that serious infectious diseases have been recorded among the group.

Surgeon general report: ‘Addiction is not a character flaw’

In what may be his last significant act as President Barack Obama's surgeon general, Dr. Vivek Murthy released a report Thursday calling for a major cultural shift in the way Americans view drug and alcohol addiction. The report, "Facing Addiction in America," details the toll addiction takes on the nation _ 78 people die each day from an opioid overdose; 20 million have a substance use disorder _ and explains how brain science offers hope for recovery.

Commentary: Congratulations, Madam President

By Anthony L Hall Many of my progressive friends are having a hard time coming to terms with Donald Trump as president-elect of the United States. Some are even joining self-flagellating, flash-mob protests, which are springing all over the country, to vent their raging disbelief.

Here Are The Three Reasons Why Medicare Is Doomed

U.S. President-elect Donald Trump meets with Speaker of the House Paul Ryan on Capitol Hill in Washington, U.S., November 10, 2016. REUTERS/Joshua Roberts Whatever happened to "if it ain't broke, don't fix it?" Despite support for Medicare - the nation's health-care safety net for its senior population - many tea-leaf readers are predicting that the Yes, he is just the Speaker of the House and Donald Trump is the President-elect.

Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who…

The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased American Depositary Shares of Teva between February 10, 2015 and November 3, 2016 .  The case, Galmi v. Teva Pharmaceutical Industries Limited et al , No.

Bernie Is So Not Done

If you're feeling bereft, take note: Bernie Sanders is still here loudly fighting the good fight, this week blasting the avarice of Big Pharma so persuasively he sent their stock prices plunging to a seven-month low. After battling Big Pharma for decades - pillorying the makers of the emergency allergy injection EpiPen for obscenely jacking up their prices, recently calling out another company's price hikes on leukemia drugs, and campaigning this fall to stop price-gouging by seen by many as Ground Zero for drug companies and their 1,266 D.C. lobbyists - Bernie isn't letting up.

Sanders Takes Aim at Insulin Makers in Latest Price Attack

Makers of insulin became the latest target for Senator Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices. Shares of Eli Lilly & Co.